awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39366403-609FB353-83CC-4F9F-9617-F7803BF3AE96
Q39366403-609FB353-83CC-4F9F-9617-F7803BF3AE96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39366403-609FB353-83CC-4F9F-9617-F7803BF3AE96
Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients.
P2860
Q39366403-609FB353-83CC-4F9F-9617-F7803BF3AE96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39366403-609FB353-83CC-4F9F-9617-F7803BF3AE96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a747a5e127118a8a6fa774a8e5cfa8aa0fee79e
P2860
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d